Search company, investor...

NeuroVasx

neurovasx.com

Founded Year

1997

Stage

Series A | Alive

Total Raised

$3M

Last Raised

$3M | 22 yrs ago

About NeuroVasx

NeuroVasx is a medical device company that engages in the development and commercialization of technologies for the minimally invasive treatment of hemmorrhagic and ischemic stroke. It offers cPAX, a polymer strand delivered through a micro catheter for the minimally invasive treatment of hemorrhagic and ischemic strokes as well as for the embolization of cerebral and intracranial aneurysims, abnormal bulges, and sacs in the wall of an artery int he brain. The company's products are used to treat acute stroke and other cerebrovascular disorders.

Headquarters Location

7351 Kirkwood Lane North Suite 112

Maple Grove, Minnesota, 55369,

United States

763-315-0013

Missing: NeuroVasx's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: NeuroVasx's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

NeuroVasx Patents

NeuroVasx has filed 1 patent.

The 3 most popular patent topics include:

  • Brand management
  • Neurosurgery
  • Product management
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/10/2014

7/9/2019

Actuators, Medical equipment, Angiology, Interventional radiology, Catheters

Grant

Application Date

3/10/2014

Grant Date

7/9/2019

Title

Related Topics

Actuators, Medical equipment, Angiology, Interventional radiology, Catheters

Status

Grant

Latest NeuroVasx News

Philips Healthcare CEO DiSanzo steps down

Jul 11, 2014

He previously held the same title with hemorrhagic stroke device company NeuroVasx and had been ... U.K. pols ready for Pfizer's return, AZ cozies up to EU academia, Israeli biotech upsizes IPO July 10, 2014 Pharmaceuticals ($SLXP). Raleigh, NC-based Salix is to merge with the Irish subsidiary in a move CEO Carolyn Logan ... If Allergan has a pickup to make, make it now, shareholders say FiercePharma | July 10, 2014 could help the company snag the low tax rate that Valeant CEO J. Michael Pearson has promised as part ...

NeuroVasx Frequently Asked Questions (FAQ)

  • When was NeuroVasx founded?

    NeuroVasx was founded in 1997.

  • Where is NeuroVasx's headquarters?

    NeuroVasx's headquarters is located at 7351 Kirkwood Lane North, Maple Grove.

  • What is NeuroVasx's latest funding round?

    NeuroVasx's latest funding round is Series A.

  • How much did NeuroVasx raise?

    NeuroVasx raised a total of $3M.

  • Who are the investors of NeuroVasx?

    Investors of NeuroVasx include The Stephens Group and Miller Johnson Steichen Kinnard.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.